Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats.
about
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damageMMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assayNon-invasive markers for hepatic fibrosisImplication of CD38 gene in autophagic degradation of collagen I in mouse coronary arterial myocytes.Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis.Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients.Human Adipose Tissue Derived Extracellular Matrix and Methylcellulose Hydrogels Augments and Regenerates the Paralyzed Vocal Fold.Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker.Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathologyFuture detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist.Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker developmentExtracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adultsMicroRNA-208b Alleviates Post-Infarction Myocardial Fibrosis in a Rat Model by Inhibiting GATA4.Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency.Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future options.Molecular serum markers of liver fibrosis.Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology.Rheumatoid arthritis: a case for personalized health care?Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.Biomarkers of cartilage and surrounding joint tissue.Circulating levels of a collagen type v propeptide fragment in a carbon tetrachloride reversible model of liver fibrosis.Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.Proteomic analysis of altered extracellular matrix turnover in bleomycin-induced pulmonary fibrosis.Quantification of "end products" of tissue destruction in inflammation may reflect convergence of cytokine and signaling pathways -- implications for modern clinical chemistry.Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis.Metabolic Syndrome and Bone: Pharmacologically Induced Diabetes has Deleterious Effect on Bone in Growing Obese Rats.Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases.
P2860
Q26773289-9871A4C4-7550-4348-9D92-418CEF8AA35CQ28477074-53A1C2F1-A75B-42B2-8603-8DA97CB2BBE3Q30474093-0661B683-4007-4E10-9759-C54A4C202708Q33902352-5C98F75C-A39D-4530-BC39-260EBF55A132Q35477274-EB59E470-5324-4CD8-A4B4-5B2B7E378279Q35787865-CF6D2F3B-BA58-46BD-B77C-C8F2068591DFQ36170910-D2CBB12B-574D-41CE-A245-9F1B212EE113Q36367463-29156D53-5A80-4FE4-A9C3-CD9327FB8397Q36383073-AAE1714C-8180-4D4A-98F4-FA00E0DB65EDQ36402230-660EA74D-6D2E-40B4-8306-4D7091A59485Q36576517-DE93A828-692E-4BC5-AB65-A43D1F948083Q36672445-C7BD55C4-9A6F-494A-80DC-1D45966CFA3CQ36982011-0CEF3B1C-6F9F-4FA5-9F4E-69ABB694E23EQ37029400-558118D2-B1E0-4760-BCDF-67E4EFB98324Q37245901-7D791D33-DA67-4ACB-A3DB-A422DE66E19AQ37951107-A4C0DF91-CCED-4AC3-941E-D62A253615E0Q38032835-D3C248D9-3077-48C9-B033-99D3F9D9C835Q38068491-C5830FED-0DBD-4907-92FC-3D04BBB5E2B4Q38182471-065687E2-206D-49D5-B205-25FAAFF3A9DFQ38194032-B88FF76B-B31E-4A94-97E5-8E866240C418Q38218544-31E19CBE-78B2-4C9A-92F0-959AA8C81EC5Q38239828-E8BB74B8-0831-4976-B8BE-1DB871B42CD7Q41900346-1EA4A839-6F73-4A15-87E1-4B6D113BC6A8Q42363358-CAF41D92-5E11-41D7-9A7E-F3681D6F84D7Q42721872-274019AA-3B23-4D38-8357-F3610F3A8EFCQ44843241-D98CD572-5B1D-4E33-BF96-EB1AD975E84DQ46412441-887936E9-A212-497A-80BF-99DFD9B99596Q47381202-F7FE4001-BDC3-42C2-A018-B307B8C2C251Q49612209-70AE73E4-B39D-4A40-B5FA-65DED6574F31
P2860
Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Procollagen type I N-terminal ...... tion-induced fibrosis in rats.
@ast
Procollagen type I N-terminal ...... tion-induced fibrosis in rats.
@en
type
label
Procollagen type I N-terminal ...... tion-induced fibrosis in rats.
@ast
Procollagen type I N-terminal ...... tion-induced fibrosis in rats.
@en
prefLabel
Procollagen type I N-terminal ...... tion-induced fibrosis in rats.
@ast
Procollagen type I N-terminal ...... tion-induced fibrosis in rats.
@en
P2093
P2860
P356
P1476
Procollagen type I N-terminal ...... tion-induced fibrosis in rats.
@en
P2093
Anne-Christine Bay-Jensen
Ben Vainer
Efstathios Vassiliadis
Gervais Tougas
Morten Asser Karsdal
Sanne Skovgård Veidal
P2860
P2888
P356
10.1186/1755-1536-3-5
P577
2010-04-01T00:00:00Z
P5875
P6179
1032828659